Organigram (OGI) - 2026 Q1 - Earnings Call Transcript

Financial Data and Key Metrics Changes - In Q1, net revenue increased by 49% to CAD 65.3 million from CAD 42.7 million in the same prior year period, primarily due to growth in the Canadian business, integration of Motif, and higher international sales [17] - Adjusted gross profit for the quarter increased by 67% to CAD 23.9 million compared to CAD 14.3 million in Q1 last year, supported by higher revenue and efficiency gains [17][18] - Adjusted EBITDA in Q1 was CAD 5.3 million, up 273% from CAD 1.4 million in the prior year period, driven by increased scale and higher international sales [20][21] - Net income for the quarter was CAD 20 million compared to a net loss of CAD 23 million in the same prior year period, reflecting a CAD 43 million year-over-year improvement [21][22] Business Line Data and Key Metrics Changes - In Q1, the company harvested over 28,000 kilograms of flower, representing a 43% year-over-year increase, driven by improving yields and ongoing refinements to nutrient programs [10] - The company maintained the number one position in overall vapes with a 20.4% market share and moved to the number two position in overall pre-rolls at 7.7% [8] - In beverages, market share increased by 80 basis points year-over-year to 5.9%, while in concentrates, the company achieved a 15.5% category share [8][9] Market Data and Key Metrics Changes - The company holds the number one market share position in Canada with 11.3% total share in Q1 and 11.7% over the past 12 months [5][6] - In Quebec, the company moved up to the number three position with 9.9% market share for the quarter, driven by the success of vape launches [7] - The company outperformed in most provinces, holding 33.1% market share in New Brunswick and 21.9% in Newfoundland [8] Company Strategy and Development Direction - The company is focused on operational execution, improving margins, and delivering to markets while also looking at future international expansion opportunities [29][30] - The company aims to balance risk and growth opportunities in international markets while maintaining a strong focus on consumer needs and innovation [30] - The company is optimistic about long-term growth in the cannabis industry and its ability to compete and lead as the market matures [5] Management's Comments on Operating Environment and Future Outlook - Management noted that Q1 results reflected strong year-over-year revenue and adjusted EBITDA growth, despite seasonal resets and operational pressures [16] - The company remains confident in its ability to deliver against full-year guidance of revenue exceeding CAD 300 million, supported by improving fundamentals and expanding margins [24] - Management expressed optimism about international sales growth in fiscal 2026, despite a temporary decline in international volumes due to product specifications [12][13] Other Important Information - The company announced a proprietary breakthrough in powdery mildew resistance, allowing for early screening of seedlings and reducing crop loss [11] - The company completed commissioning of its beverage line and began in-house production to support portfolio expansion [12] - The company is preparing for EU GMP certification and is working closely with regulators to address feedback received [13][48] Q&A Session Summary Question: Near-term opportunities and long-term initiatives - Management emphasized the importance of operational execution and cost management as short-term priorities, while focusing on international expansion as a long-term goal [29][30] Question: Insight on international volumes and flower issues - Management acknowledged stringent international flower requirements and identified core drivers of recent issues, expecting to resolve them soon [35] - The estimated impact of the flower issues was approximately CAD 3.5 million on international revenue [36] Question: Recovery in the Canadian market - Management confirmed that distribution levels in BC have returned to normal and expressed confidence in recovering market share despite increased competition [42] Question: EU GMP certification timeline - Management stated they are working closely with regulators to address questions and are aiming for the fastest resolution possible, but could not provide a specific timeline [48] Question: Route to market in Europe - Management indicated a mixed approach for market entry, utilizing both direct sales and partnerships depending on regulations and market conditions [52] Question: U.S. market strategy and regulatory environment - Management noted that the U.S. market is currently a small part of their business and emphasized a cautious approach to investments due to regulatory uncertainties [55][56] Question: Increased competition in pre-rolls - Management acknowledged competitive pressures across all categories, particularly in pre-rolls and vapes, and highlighted upcoming product innovations to address these challenges [60]